ALPHARETTA, GA, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- MagVenture, the global leader of non-invasive TMS neuromodulation technology, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for an expanded …